Clinical Trials Logo

Filter by:
NCT ID: NCT00848549 Completed - Epilepsy Clinical Trials

Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures

Start date: October 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the long-term safety and tolerability and to explore the long-term efficacy of zonisamide as monotherapy treatment in subjects with newly diagnosed partial seizures.

NCT ID: NCT00825058 Completed - Clinical trials for Major Depressive Disorders

Efficacy and Safety of SR58611 Compared to Placebo and Paroxetine

Start date: November 2003
Phase: Phase 3
Study type: Interventional

Primary objective : - To demonstrate the antidepressant efficacy on the Hamilton Depression Rating Scale of SR58611A 700mg/day compared with placebo in the treatment of patients with a recurrent major depressive episode. Secondary objectives: - To assess the safety profile of SR58611A 700 mg/d in comparison to placebo and to assess plasma concentrations of the active metabolite.

NCT ID: NCT00465491 Active, not recruiting - Clinical trials for Small Cell Lung Cancer

Study of Picoplatin Efficacy After Relapse

SPEAR
Start date: April 2007
Phase: Phase 3
Study type: Interventional

Picoplatin is a new type of platinum drug that has been investigated in several clinical trials, and may provide an improved safety profile over current treatment options. This study is designed to compare the efficacy and safety of picoplatin plus Best Supportive Care (BSC) with BSC alone. Best Supportive Care includes care and treatment to optimize the comfort of patients and their ability to function, as well as to minimize the side-effects of anti-cancer treatments.

NCT ID: NCT00294437 Terminated - Prostate Cancer Clinical Trials

ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases

Start date: December 2003
Phase: Phase 3
Study type: Interventional

To determine if therapy with Zometa® (zoledronic acid) 4mg will be effective in preventing the occurrence of bone metastases in prostate cancer patients at high risk of developing them. In addition, pain and analgesic scores and overall safety are to be evaluated throughout the study.

NCT ID: NCT00268892 Completed - Prostate Cancer Clinical Trials

Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer

Start date: January 2006
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this extension study was to collect long-term safety and tolerability information to support a marketing authorisation application for a three-month dosage regimen of degarelix.